Validation of the French Translation of the Scale HSCL25 in the Diagnosis of Depression in Primary Care

NCT ID: NCT02414711

Last Updated: 2025-12-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1128 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-06-30

Study Completion Date

2016-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Depression has emotional consequences, social and important business. Reaching at least 7.5% of French aged 15 to 85 years. General Practitioners are the first professional consulted in terms of frequency of consultations. Indeed, in primary care, 10 to 25% of patients with depression that General Practitioners are often alone to support and follow. But General Practitioners are faced with diagnostic difficulties facing the diagnosis of depression, because if the patient does not engage itself, no tool is validated in France to help them in their diagnosis. However, standardized questionary exist that allow to overcome this difficulty. Questionary used in other european countries. Among them, the HSCL25 scale was selected by a systematic review of literature and a RAND UCLA type of consensus procedure. This HSCL25 scale is the most efficient for the diagnosis of depression in terms of efficiency tool, reproducibility and ergonomics. However, it remains necessary to confirm its validity in terms of the French translation and in terms of efficiency.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No depressed

If the result of the HSCL25 scale is inferior than 1.75, then the patient is considered as no depressed.

50 of these patients have to have a psychological interview with the PSE9 questionary to validate the result of the HSCL25 scale.

Group Type OTHER

HSCL25 scale

Intervention Type OTHER

The patient must answer to 25 questions of the HSCL25 scale. In function of the results, the patients was diagnosed depressed (≥1.75) or not depressed (\<1.75)

PSE9 questionary

Intervention Type OTHER

On the 900 patients recruited, 50 patients who was diagnosed depressed or no depressed have to have a psychological interview with the PSE9 questionary to validate the first diagnosis done by the HSCL25 scale

Depressed

If the result of the HSCL25 scale is superior or equal to 1.75, then the patient is considered as depressed.

50 of these patients have to have a psychological interview with the PSE9 questionary to validate the result of the HSCL25 scale.

Group Type OTHER

HSCL25 scale

Intervention Type OTHER

The patient must answer to 25 questions of the HSCL25 scale. In function of the results, the patients was diagnosed depressed (≥1.75) or not depressed (\<1.75)

PSE9 questionary

Intervention Type OTHER

On the 900 patients recruited, 50 patients who was diagnosed depressed or no depressed have to have a psychological interview with the PSE9 questionary to validate the first diagnosis done by the HSCL25 scale

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HSCL25 scale

The patient must answer to 25 questions of the HSCL25 scale. In function of the results, the patients was diagnosed depressed (≥1.75) or not depressed (\<1.75)

Intervention Type OTHER

PSE9 questionary

On the 900 patients recruited, 50 patients who was diagnosed depressed or no depressed have to have a psychological interview with the PSE9 questionary to validate the first diagnosis done by the HSCL25 scale

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult (18 and over) consultant in primary care

Exclusion Criteria

* Child or young person under 18
* Women with a declared pregnancy to prevent puerperal depression whose support is different.
* Adult consultant to obtain a medical certificate
* Psychotic patients and\\or requiring immediate care
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Brest

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Patrice NABBE, GP

Role: PRINCIPAL_INVESTIGATOR

GP department

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cabinet médical en zone urbaine

Brest, France, France

Site Status

Cabinet médical en zone rurale - Pôle Santé Universitaire

Lanmeur, France, France

Site Status

Cabinet médical en zone semi-rurale

Plounéour-Trez, France, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Nabbe P, Le Reste JY, Guillou-Landreat M, Gatineau F, Le Floch B, Montier T, Van Marwijk H, Van Royen P. The French version of the HSCL-25 has now been validated for use in primary care. PLoS One. 2019 Apr 4;14(4):e0214804. doi: 10.1371/journal.pone.0214804. eCollection 2019.

Reference Type RESULT
PMID: 30946774 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HSCL25 Validation

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Improving Depression Management
NCT05050227 COMPLETED NA